Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group
- 1 September 2003
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 9 (9), 980-983
- https://doi.org/10.1046/j.1469-0691.2003.00690.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Establishing MIC breakpoints and the interpretation of in vitro susceptibility testsJournal of Antimicrobial Chemotherapy, 2001
- Characterization ofPseudomonas aeruginosaIsolates: Occurrence Rates, Antimicrobial Susceptibility Patterns, and Molecular Typing in the Global SENTRY Antimicrobial Surveillance Program, 1997–1999Clinical Infectious Diseases, 2001
- Of Pseudomonas, porins, pumps and carbapenemsJournal of Antimicrobial Chemotherapy, 2001
- Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosaJournal of Antimicrobial Chemotherapy, 2000
- The MYSTIC (meropenem yearly susceptibility test information collection) programmeInternational Journal of Antimicrobial Agents, 1999
- Epidemiology and Clinical Outcomes of Patients with Multiresistant Pseudomonas aeruginosaClinical Infectious Diseases, 1999
- Carbapenem Activities against Pseudomonas aeruginosa : Respective Contributions of OprD and Efflux SystemsAntimicrobial Agents and Chemotherapy, 1999
- Bacterial Resistance: A Worldwide ProblemDiagnostic Microbiology and Infectious Disease, 1998
- Imipenem‐ResistantPseudomonas aeruginosa: Risk Factors and Antibiotic Susceptibility PatternsClinical Infectious Diseases, 1997